Pharmaceutical
Home » H2-Receptor Antagonists Market

H2-Receptor Antagonists Market

H2-Receptor Antagonists Market: Growth, Future Prospects & Competitive Analysis, 2018-2026
Report Book

Published Date: May 2018
Category: Pharmaceuticals
Report ID: 59127
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

The global H2-receptor antagonists (H2RA) market is projected to grow at a higher CAGR within the forecast period from 2018 to 2026. H2-receptor antagonists play a very important role in preventing the secretion of gastric acid and treating duodenal ulcers, peptic ulcers, and esophageal ulcers. There is a vast range of H2RA products available in the market in the form of tablets, solutions, and forecast period from 2018 to 2026. H2-receptor antagonists play a very important role in preventing the secretion of gastric acid and treating duodenal ulcers, peptic ulcers, and esophageal ulcers. There are a vast range of H2RA products available in the market in the form of tablets, solutions, injectables, and so on, which can be easily obtained through prescriptions or over-the-counter (OTC) channels. According to the Centers for Disease Control and Prevention (CDC), every year in the United States, around 6 million individuals get affected by peptic ulcer disease (PUD).

The surge in the utilization of non-steroidal anti-inflammatory drugs (NSAIDs) due to the growing prevalence of inflammatory diseases, for example, aspirin, and growing awareness related to the better treatment options for gastroesophageal reflux disease and Zollinger-Ellison syndrome will drive the growth of the H2-receptor antagonists market during the forecast period from 2018 to 2026.

Factors driving the growth of the H2-receptor antagonist market include the rising prevalence of peptic ulcers, aggravated by sedentary lifestyles and unhealthy diets, and the growth in the smoking rate. Additionally, the easy availability of treatment medications and improved diagnostic techniques further facilitate the market’s growth. The increasing occurrence of complications related to peptic ulcers, such as bleeding and perforation, are the main considerations driving the worldwide H2-receptor antagonist market. Along with peptic ulcers, the growing prevalence of other conditions, such as esophageal ulcers and duodenal ulcers, will also drive the H2-receptor antagonist market.

The global H2-receptor antagonists market is classified as follows:

Global H2-Receptor Antagonists Market, by Product Types, 2016–2026 (US$ Mn)

  • Tablets
  • Solutions
  • Injectable
  • Others (capsule, syrup, powder for suspension)

Global H2-Receptor Antagonists Market, by Drug Class, 2016–2026 (US$ Mn)

  • Cimetidine
  • Famotidine
  • Nizatidine
  • Ranitidine

Global H2-Receptor Antagonists Market, by Geography, 2016–2026 (US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The following companies have been identified as key players in the H2-Receptor Antagonists Market:

Tocris Bioscience, GlaxoSmithKline plc, Modi Lifecare Industries Limited, Merck & Company, Inc., Apex Biotechnology Corp., Inc., Axon Medchem, Medochemie, and others

This report offers the following:

  • A summary of the global market for h2-receptor antagonists
  • Company profiles emphasize key information about the main players functioning in the h2-receptor antagonist market
  • Highlighting every level of market category based on product approvals and existing and predicted market dynamics
  • Qualitative evaluation tools such as challenges, market drivers, and future scenarios
  • Competitive landscape and market share analysis are two market competition investigation tools.
  • A collective overview of the industry structure

Frequently Asked Questions:

What is the size of H2-Receptor Antagonists Market?

The market for H2-Receptor Antagonists Market is expected to reach USD$ XX Mn in 2026.

What is the H2-Receptor Antagonists Market CAGR?

The H2-Receptor Antagonists Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for H2-Receptor Antagonists Market?

The report is forecasted from 2018 -2026.

What is the base year considered for H2-Receptor Antagonists Market?

The base year of this report is 2017.

Who are the major players in this market?

Tocris Bioscience, GlaxoSmithKline plc, Modi Lifecare Industries Limited, Merck & Company, Inc., Apex Biotechnology Corp., Inc., Axon Medchem, Medochemie. are some of the major players in the global market.

Download Sample Report


Have a question?

Market Research Analyst

Don’t settle for less – trust Ishika to help you find the best solution.

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 8085 89 5002


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN